News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
757,362 Results
Type
Article (46108)
Company Profile (472)
Press Release (710763)
Multimedia
Podcasts (141)
Webinars (26)
Section
Business (212753)
Career Advice (2140)
Deals (36588)
Drug Delivery (142)
Drug Development (84799)
Employer Resources (178)
FDA (16931)
Job Trends (15415)
News (359464)
Policy (33817)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2755)
Accelerated approval (48)
Adcomms (33)
Allergies (172)
Alliances (51798)
ALS (209)
Alzheimer's disease (1837)
Antibody-drug conjugate (ADC) (459)
Approvals (17255)
Artificial intelligence (666)
Autoimmune disease (263)
Automation (52)
Bankruptcy (375)
Best Places to Work (11960)
BIOSECURE Act (20)
Biosimilars (220)
Biotechnology (330)
Bladder cancer (189)
Brain cancer (73)
Breast cancer (736)
Cancer (5808)
Cardiovascular disease (479)
Career advice (1820)
Career pathing (46)
CAR-T (330)
CDC (57)
Celiac Disease (2)
Cell therapy (892)
Cervical cancer (45)
Clinical research (73010)
Collaboration (2127)
Company closure (4)
Compensation (1353)
Complete response letters (88)
COVID-19 (2821)
CRISPR (112)
C-suite (1116)
Cystic fibrosis (159)
Data (7631)
Decentralized trials (3)
Denatured (45)
Depression (170)
Dermatology (73)
Diabetes (578)
Diagnostics (7071)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (331)
Drug pricing (213)
Drug shortages (32)
Duchenne muscular dystrophy (292)
Earnings (94071)
Editorial (69)
Employer branding (21)
Employer resources (156)
Events (124875)
Executive appointments (1105)
FDA (20587)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1754)
Gene editing (245)
Generative AI (57)
Gene therapy (746)
GLP-1 (1097)
Government (4898)
Grass and pollen (6)
Guidances (405)
Healthcare (19552)
HIV (81)
Huntington's disease (54)
IgA nephropathy (97)
Immunology and inflammation (309)
Immuno-oncology (94)
Indications (173)
Infectious disease (3163)
Inflammatory bowel disease (220)
Inflation Reduction Act (17)
Influenza (139)
Intellectual property (285)
Interviews (330)
IPO (17099)
IRA (53)
Job creations (3797)
Job search strategy (1517)
JPM (67)
Kidney cancer (18)
Labor market (97)
Layoffs (600)
Leadership (42)
Legal (8158)
Liver cancer (101)
Longevity (31)
Lung cancer (780)
Lymphoma (426)
Machine learning (59)
Management (61)
Manufacturing (1013)
MASH (187)
Medical device (14268)
Medtech (14358)
Mergers & acquisitions (20703)
Metabolic disorders (1525)
mRNA (219)
Multiple sclerosis (186)
NASH (20)
Neurodegenerative disease (426)
Neuropsychiatric disorders (110)
Neuroscience (3369)
Neurotech (1)
NextGen: Class of 2026 (6863)
Non-profit (4694)
Now hiring (75)
Obesity (732)
Opinion (318)
Ovarian cancer (209)
Pain (251)
Pancreatic cancer (294)
Parkinson's disease (374)
Partnered (35)
Patents (579)
Patient recruitment (651)
Peanut (62)
People (61886)
Pharmaceutical (82)
Pharmacy benefit managers (33)
Phase 1 (22904)
Phase 2 (32178)
Phase 3 (23817)
Pipeline (7920)
Policy (328)
Postmarket research (2684)
Preclinical (9853)
Press Release (68)
Prostate cancer (297)
Psychedelics (61)
Radiopharmaceuticals (342)
Rare diseases (1102)
Real estate (6205)
Recruiting (72)
Regulatory (26107)
Reports (55)
Research institute (2565)
Resumes & cover letters (364)
Rett syndrome (36)
RNA editing (25)
RSV (88)
Schizophrenia (180)
Series A (296)
Series B (219)
Service/supplier (11)
Sickle cell disease (118)
Special edition (27)
Spinal muscular atrophy (170)
Sponsored (48)
Startups (3857)
State (2)
Stomach cancer (19)
Supply chain (130)
Tariffs (90)
The Weekly (93)
Vaccines (1123)
Venture capital (112)
Weight loss (479)
Women's health (123)
Worklife (22)
Date
Today (189)
Last 7 days (724)
Last 30 days (2900)
Last 365 days (31348)
2026 (10489)
2025 (31253)
2024 (36480)
2023 (41258)
2022 (52588)
2021 (57134)
2020 (55418)
2019 (48138)
2018 (36258)
2017 (33567)
2016 (33001)
2015 (39129)
2014 (32883)
2013 (27762)
2012 (29967)
2011 (30535)
2010 (28703)
Location
Africa (801)
Alabama (97)
Alaska (7)
Arizona (355)
Arkansas (16)
Asia (42290)
Australia (7076)
California (13000)
Canada (3680)
China (1354)
Colorado (557)
Connecticut (571)
Delaware (391)
Europe (93785)
Florida (1921)
Georgia (414)
Hawaii (3)
Idaho (62)
Illinois (1045)
India (92)
Indiana (590)
Iowa (25)
Japan (525)
Kansas (133)
Kentucky (50)
Louisiana (41)
Maine (87)
Maryland (1558)
Massachusetts (9390)
Michigan (366)
Minnesota (709)
Mississippi (6)
Missouri (154)
Montana (35)
Nebraska (29)
Nevada (138)
New Hampshire (89)
New Jersey (3446)
New Mexico (31)
New York (3404)
North Carolina (1729)
North Dakota (9)
Northern California (6444)
Ohio (386)
Oklahoma (24)
Oregon (45)
Pennsylvania (2600)
Puerto Rico (28)
Rhode Island (51)
South America (1170)
South Carolina (85)
South Dakota (2)
Southern California (5104)
Tennessee (206)
Texas (2059)
United States (46180)
Utah (386)
Vermont (1)
Virginia (310)
Washington D.C. (82)
Washington State (1067)
West Virginia (4)
Wisconsin (135)
Wyoming (2)
757,362 Results for "phage therapeutics international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
February 12, 2026
·
6 min read
Press Releases
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
April 1, 2026
·
3 min read
Press Releases
Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
April 24, 2026
·
6 min read
Deals
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing
BiomX Inc. today announced that it has entered into a definitive merger agreement with Adaptive Phage Therapeutics, Inc. (“APT”), a U.S.-based privately-held, clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections (the “Acquisition”).
March 6, 2024
·
15 min read
Press Releases
enGene Announces Name Change to enGene Therapeutics Inc.
April 7, 2026
·
8 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
April 23, 2026
·
6 min read
Deals
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
BiomX Inc. announced the closing of its previously announced acquisition of Adaptive Phage Therapeutics, Inc. and its previously announced $50 million private placement to certain institutional accredited investors, which was led by affiliates of Deerfield Management Company and the AMR Action Fund, and additional investors including the Cystic Fibrosis Foundation, OrbiMed and Nantahala Capital.
March 18, 2024
·
11 min read
Press Releases
iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application
August 6, 2025
·
4 min read
Press Releases
Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites
February 17, 2026
·
2 min read
Press Releases
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
April 17, 2026
·
2 min read
1 of 75,737
Next
